CQS
ABCL icon

Credential Qtrade Securities’s AbCellera Biologics ABCL Stock Holding History

Credential Qtrade Securities’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-109
Closed -$1.08K – 339
2022
Q3 		$1.08K Hold
109
– – ﹤0.01% 360
2022
Q2 		$1.16K Hold
109
– – ﹤0.01% 343
2022
Q1 		$1.06K Hold
109
– – ﹤0.01% 345
2021
Q4 		$1.56K Hold
109
– – ﹤0.01% 348
2021
Q3 		$2.18K Sell
109
-26,450
-100% -$468K ﹤0.01% 330
2021
Q2 		$584K Buy
26,559
+26,450
+24,266% +$729K 0.05% 165
2021
Q1 		$3.7K Buy
+109
New +$4.34K ﹤0.01% 323

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credential Qtrade Securities's ABCL Position: Q4 2022 in Review

Credential Qtrade Securities sold out of AbCellera Biologics (ABCL) in Q4 2022, closing a stake of 109 shares — an estimated $1.08K sold.

Credential Qtrade Securities first reported a position in ABCL in Q1 2021 and held it in 7 quarters. The position peaked at $584K in Q2 2021. 201 funds tracked by Wall St. Rank hold ABCL as of Q4 2022.

  • Credential Qtrade Securities reported no remaining AbCellera Biologics position as of Q4 2022 after selling out during the quarter.
  • Credential Qtrade Securities sold 109 AbCellera Biologics shares in Q4 2022, an estimated $1.08K.
  • Credential Qtrade Securities first reported a position in AbCellera Biologics in Q1 2021 and held it in 7 quarters.
  • Credential Qtrade Securities's AbCellera Biologics position peaked at $584K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2022.

Based on Credential Qtrade Securities's 13F filing for Q4 2022, filed 21 Jul 2025.